Chronic rhinosinusitis: the rationale for current treatments
Authors:
- 24 August 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 13 (3) , 259-270
Abstract
Chronic rhinosinusitis (CRS) is a broad clinical syndrome linked by mucosal inflammation. Primary treatment modalities are corticosteroids and antibiotics with surgery an option for failures, but the level of supporting evidence is generally low. The primary reason is that CRS is a symptom complex and not a specific disease. Areas covered: The primary treatment modalities for CRS are corticosteroids, antibiotics and surgery. Corticosteroids, which have very broad anti-inflammatory properties, also have the strongest evidence for efficacy. Antibiotics are likely effective in a subpopulation of patients but the various phenotypes and endotypes that make up CRS have thus far been poorly defined. Early surgery as well as biologics may also be more efficacious and cost effective in some phenotypes as well. Expert commentary: A better understanding of the inflammatory pathways that drive CRS will permit investigators to separate patient groups. This will allow for clinical trials that target specific subpopulations and more personalized therapy for CRS patients in the future.Keywords
This publication has 136 references indexed in Scilit:
- Comparison of endoscopically‐guided swab vs aspirate culture techniques in post–endoscopic sinus surgery patients: blinded, prospective analysisInternational Forum of Allergy & Rhinology, 2013
- Impact of tobacco smoke on chronic rhinosinusitis: a review of the literatureInternational Forum of Allergy & Rhinology, 2012
- Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitisThe Laryngoscope, 2012
- Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2011
- Update on bacterial detection methods in chronic rhinosinusitis: implications for clinicians and research scientistsInternational Forum of Allergy & Rhinology, 2011
- Safety and efficacy of a novel bioabsorbable, steroid‐eluting sinus stentInternational Forum of Allergy & Rhinology, 2011
- Epithelial tight junction alterations in nasal polyposisInternational Forum of Allergy & Rhinology, 2011
- Long‐term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitisThe Laryngoscope, 2009
- Montelukast as an Adjunct to Oral and Inhaled Steroid Therapy in Chronic Nasal PolyposisOtolaryngology–Head and Neck Surgery, 2008
- Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatmentsAllergy, 2005